Europe’s Biotechs Break Records With Circassia IPO, Inotrem‘s Series A
This article was originally published in The Pink Sheet Daily
Executive Summary
Confidence returns to Europe’s biotech investors with a biotech IPO on the London Stock Exchange and the largest Series A round for a European biotech this year.